108 related articles for article (PubMed ID: 6743811)
1. [Delayed hypersensitivity reaction to alloantigens in mice].
Cherniakhovskaia IIu; Liadova IV; Fontalin LN
Biull Eksp Biol Med; 1984 Jun; 97(6):706-8. PubMed ID: 6743811
[TBL] [Abstract][Full Text] [Related]
2. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
[TBL] [Abstract][Full Text] [Related]
3. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity to transplantation antigens in mice and its investigation under conditions of allograft and xenograft tolerance.
Chernyakhovskaya IYu ; Lyadova IV
Folia Biol (Praha); 1987; 33(3):166-76. PubMed ID: 3497824
[TBL] [Abstract][Full Text] [Related]
5. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens.
Williamson JS; Streilein JW
Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells.
Sano S; Suda T; Qian JH; Sato S; Ikegami R; Hamaoka T; Fujiwara H
J Immunol; 1987 Dec; 139(11):3652-9. PubMed ID: 3680947
[TBL] [Abstract][Full Text] [Related]
7. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
J Surg Res; 2002 May; 104(1):29-35. PubMed ID: 11971674
[TBL] [Abstract][Full Text] [Related]
8. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
Hori J; Joyce NC; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
[TBL] [Abstract][Full Text] [Related]
9. [Suppressors of the graft vs graft reaction in tolerance to alloantigens].
Cherniakhovskaia IIu; Prigozhina TB; Nagurskaia EV; Fontalin LN
Biull Eksp Biol Med; 1988 Jun; 105(6):697-700. PubMed ID: 2968819
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388
[TBL] [Abstract][Full Text] [Related]
11. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
12. [Delayed hypersensitivity reaction to rat xenoantigens in mice].
Liadova IV; Cherniakhovskaia IIu
Biull Eksp Biol Med; 1985 Dec; 100(12):762-5. PubMed ID: 3878164
[TBL] [Abstract][Full Text] [Related]
13. A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA.
Havelková H; Badalová J; Demant P; Lipoldová M
Genes Immun; 2000 Dec; 1(8):483-7. PubMed ID: 11197689
[TBL] [Abstract][Full Text] [Related]
14. [Genetic restriction on interaction between the effects of delayed hypersensitivity and suppressor cells].
Fontalin DN; Chernousov AD; Cherniakhovskaia IIu
Biull Eksp Biol Med; 1981 Aug; 92(8):58-61. PubMed ID: 6457654
[TBL] [Abstract][Full Text] [Related]
15. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
16. Acquired immunity to Salmonella typhimurium and delayed (footpad) hypersensitivity in BALB/c mice.
Hormaeche CE; Fahrenkrog MC; Pettifor RA; Brock J
Immunology; 1981 Jul; 43(3):547-54. PubMed ID: 7019057
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
Sun JB; Li BL; Czerkinsky C; Holmgren J
Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
[TBL] [Abstract][Full Text] [Related]
18. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
[TBL] [Abstract][Full Text] [Related]
19. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts.
Sonoda Y; Streilein JW
J Immunol; 1993 Mar; 150(5):1727-34. PubMed ID: 8436812
[TBL] [Abstract][Full Text] [Related]
20. Prevention of suppression of alloreactive capacity following intravenous injection of neuraminidase-treated allogeneic cells by co-injection of agents competing for asialoglycoprotein receptor.
Suda T; Sano S; Hori S; Azuma T; Tateishi N; Hamaoka T; Fujiwara H
Reg Immunol; 1988; 1(1):24-31. PubMed ID: 3275127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
